Open AccessClinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii
Author(s) -
Sara Alosaimy,
Taylor Morrisette,
Abdalhamid M Lagnf,
Leonor M. Rojas,
Madeline King,
Benjamin Pullinger,
Athena L V Hobbs,
Nicholson B Perkins,
Michael P Veve,
Jeannette Bouchard,
Tristan Gore,
Bruce M Jones,
James Truong,
Justin Andrade,
Glen Huang,
Reese Cosimi,
S Lena Kang-Birken,
Kyle C Molina,
Mark Biagi,
Michael Pierce,
Marco R. Scipione,
Jing Zhao,
Susan L. Davis,
Michael J. Rybak
Publication year - 2022
Publication title -
microbiology spectrum
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.502
H-Index - 51
ISSN - 2165-0497
DOI - 10.1128/spectrum.00479-22
Subject(s) - acinetobacter baumannii , carbapenem , medicine , guideline , acinetobacter , microbiology and biotechnology , intensive care medicine , antibiotics , biology , pseudomonas aeruginosa , bacteria , pathology , genetics